Trademarkia Logo

Canada

C$
LONBRYTOS
APPROVED

on 15 Apr 2025

Last Applicant/ Owned by

Boehringer Ingelheim International GmbH

55218 Ingelheim

DE

Serial Number

2237102 filed on 19th Dec 2022

Correspondent Address

MARKS & CLERK

180 Kent StreetSuite 1900Ottawa

ONTARIO

CA

K1P0B6

LONBRYTOS

Trademark usage description

pharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism, namely, renal diseases, Read More

Classification Information


Class [005]
Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism, namely, renal diseases, liver diseases, pancreas diseases, digestive system disorders, gastrointestinal diseases and disorders, obesity; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the blood and blood forming organs, namely, vascular diseases, hematology, blood disorders; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system and respiratory system; pharmaceutical preparations for the prevention and treatment of genitourinary diseases, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders, damaged skin and tissues namely, rashes, sores, psoriasis, eczema; pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases and disorders; pharmaceutical preparations for the prevention and treatment of ophthalmological diseases and disorders; pharmaceutical preparations for the treatment and prevention of hormonal diseases and disorders; pharmaceutical preparations for the treatment and prevention of infectious diseases and disorders and viral infections, namely, antibiotics, anti-infectives, antivirals; pharmaceutical preparations for the prevention and treatment of oncological and auto-immune diseases and disorders; pharmaceutical preparations, namely, cell-based immune therapeutics for treatment cancer, for treatment of immunological diseases and treatment of infectious diseases, namely viral infections.


Classification kind code

11

Mark Details


Serial Number

2237102

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 48
on 10th Sept 2024
Agent Changed
Submitted for opposition 20
on 7th May 2024
Examiner's First Report
Submitted for opposition 223
on 7th May 2024
Total Provisional Refusal
Submitted for opposition 22
on 6th May 2024
Search Recorded
Submitted for opposition 256
on 4th Dec 2023
Notification of Possible Opposition Sent
Submitted for opposition 257
on 2th Feb 2023
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 1st Feb 2023
Created
Submitted for opposition 31
on 1st Feb 2023
Formalized
Submitted for opposition 30
on 19th Dec 2022
Filed
Submitted for opposition 228
on 19th Dec 2022
International Registration

This website uses cookies

We use cookies to ensure you get the best experience. Check our Privacy Policy and Terms & Conditions.
Manage cookies

Manage cookies

You can choose to enable or disable some or all of these cookies but disabling some of them may affect your browsing experience.

Advertisement

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously

Analytics

Analytical cookies are used to understand how visitors interact with the website.

Functional

Functional cookies help perform certain functionalities like collecting feedback, and other third-party features.

Performance

Performance cookies are used to understand and analyze the key performance indexes of the website.